Seeking Alpha

BioMimetic Therapeutics (BMTI +12.2%) soars a day after reporting positive data from a small...

BioMimetic Therapeutics (BMTI +12.2%) soars a day after reporting positive data from a small trial testing its augment bone graft device in patients undergoing surgery for rotator cuff injuries. The FDA last month declined to approve the graft and sought more data, but the new information boosts hopes of attracting interest from potential partners.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector